Sam Jactel
Direktor/Vorstandsmitglied bei Hypercell Technologies, Inc.
Aktive Positionen von Sam Jactel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hypercell Technologies, Inc.
Hypercell Technologies, Inc. Packaged SoftwareTechnology Services Hypercell Technologies, Inc. has developed a proprietary point-of-care diagnostic technology platform that allows for the early identification and management of biological contaminants in the food chain, from production to transformation. The private company is based in Brookhaven, GA and was founded by Bruno Jactel, who has been the CEO since incorporation. Despite advances in vaccines and testing tools, production animal diseases still cost $10 billion in lost productivity and threaten the human population when animal diseases jump to the human species. Food-borne diseases impact 48 million Americans every year and cost the economy more than $55 billion/year. Hypercell's solution is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Sam Jactel
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Hypercell Technologies, Inc.
Hypercell Technologies, Inc. Packaged SoftwareTechnology Services Hypercell Technologies, Inc. has developed a proprietary point-of-care diagnostic technology platform that allows for the early identification and management of biological contaminants in the food chain, from production to transformation. The private company is based in Brookhaven, GA and was founded by Bruno Jactel, who has been the CEO since incorporation. Despite advances in vaccines and testing tools, production animal diseases still cost $10 billion in lost productivity and threaten the human population when animal diseases jump to the human species. Food-borne diseases impact 48 million Americans every year and cost the economy more than $55 billion/year. Hypercell's solution is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. | Technology Services |
- Börse
- Insiders
- Sam Jactel
- Erfahrung